中国寄生虫学与寄生虫病杂志 ›› 1998, Vol. 16 ›› Issue (5): 335-341.

• 论著 • 上一篇    下一篇

左旋吡喹酮、右旋吡喹酮和消旋吡喹酮的体外与体内抗不同发育期日本血吸虫的作用(英文)

肖树华1; 尤纪青1; 梅静艳1; 胡玉琴1; 周德涵1; Brian A. Catto 2   

  1. 中国预防医学科学院寄生虫病研究所
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:1998-10-31 发布日期:1998-10-31

IN VITRO AND IN VIVO EFFECT OF LEVOPRAZIQUANTEL, DEXTROPRAZIQUANTEL VERSUS RACEMIC PRAZIQUANTEL ON DIFFERENT DEVELOPMENTAL STAGES OF SCHISTOSOMA JAPONICUM

Xiao Shuhua 1; You Jiqing 1; Mei Jinyan 1; Hu Yuqin 1; Zhou Dehan 1; Brian A.
Catto 2   

  1. 1 Institute of Parasitic Diseases; Chinese Academy of Preventive Medicine; WHO Collaborating Center for Malaria; Schistosomiasis and Filariasis; Shanghai 200025, China 2 Hospital Epidemiology/Infectious Diseases Section, Veterans Administration Medical Center/Medical College of Georgia, Augusta, Georgia 30912
  • Received:1900-01-01 Revised:1900-01-01 Online:1998-10-31 Published:1998-10-31

摘要: 目的:测定消旋吡喹酮(Pra)、左旋吡喹酮(L-Pra)和右旋吡喹酮(D-Pra)对不同发育期日本血吸虫的作用。方法:用含20%小牛血清的PRMI1640培养不同发育期的血吸虫,测定上述三种药物的体外抗血吸虫作用。体内试验系于小鼠感染血吸虫尾蚴后不同时间灌服(ig)Pra、L-Pra或D-Pra,根据残留平均虫数评估药效。结果:依据药物引起虫的皮层损害程度,虫龄为28d(d28)和35d(d35)的成虫对L-Pra最敏感,而14d(d14)童虫则最不敏感。在药物浓度为0.1-1μg/ml时,L-Pra的抗血吸虫作用较Pra的为强,即使L-Pra的浓度减至Pra最低有效药浓度的1/2亦有效。在体外,上述浓度的D-Pra对不同发育期血吸虫无明显作用。感染小鼠ig单剂量的L-Pra,Pra或D-Pra300mg/kg或500mg/kg,仅前2种药物对3h(do)、21d(d21)童虫和d28及d35成虫有较明显的疗效,而对3d(d3)、7d(d7)和d14童虫的疗效甚差或无效。与L-Pra和Pra相比,D-Pra仅对d35成虫有较差的疗效。感染d35血吸虫成虫的小鼠用L-Pra150mg/kgig治疗,其疗效与用Pra 300mg/kg 治疗的相仿。D-Pra 的总剂量增至L -Pra 的2—6 倍时亦仅示很差的疗效。结论: 在消旋Pra 中,L-Pra 是抗血吸虫的活性成分。

关键词: 日本血吸虫, 对映体, 吡喹酮, 左旋吡喹酮, 右旋吡喹酮, 疗效

Abstract: AIM: To compare the antischistosomal effect of racemic praziquantel (Pra) and its
enantiomers, levopraziquantel (L Pra) and dextropraziquantel (D Pra), on different developmental
stages of Schistosoma japonicum. METHODS: The in vitro effects of the drugs were determined in
different stages of schistosomes maintained in RPMI 1640 supplemented with 20% calf serum. In
vivo study mice infected with schistosome cercariae were treated intragastrically (ig) with Pra,
L-Pra or D-Pra at different intervals after infection. The efficacy of the drugs was evaluated by residualmean worm number. RESULTS: Based on the degree of tegument damage induced by L-Pra, d28 and d35 schistosomes were most susceptible to L-Pra, while d14 schistosomules being least susceptible. At comparable concentrations of 0.1- 1 g/ml, L-Pra was more active than Pra even when the concentration of L-Pra was reduced to one-half of the minimum effective concentration Of Pra. At above-mentioned concentrations D-Pra exhibited no apparent in vitro effect on different stages of schistosomes. When infected mice were treated ig with L-Pra, Pra or D-Pra at a single dose of 300mg/kg or 500 mg/kg, only the former two drugs showed apparent effect on d0, d21, d28 and d35 schistosomes and less or much less effect on d3, d7 and d14 schistosomules. D-Pra only exhibited a negligible effect on d35 adult schistosomes as compared with L-Pra and Pra. When mice infected with d35 adult schistosmes were treated ig with L-Pra 150 mg/kg, the efficacy was similar to that of mice treated with Pra 300 mg/kg. CONCLUSION: L-Pra is the principal active component against schistosomes in racemic Pra.

Key words: Schistosoma japonicum, enantiomer, praziquantel, levopraziquantel, dextropraziquantel, therapeutic effect